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 ABSTRACT 
Cereal grains and their components derived Bioactive compounds such as rice bran can 
promote health and can be derived from Rice bran contains 12-20 % protein and could be a good 
source for extracting bioactive peptides. A pentapeptide with a secqunce of amino acids Glu-
Gln-Arg-Pro-Arg (EQRPR) has been prepared from heat stablized defatted rice bran (HDRB) 
and has demonstrated anti-cancer proprerties in-vitro. This bioactive pentapeptide can thus be 
used as a nutraceutical by incorporating it into a suitable food system. Fruit juces can be vehicles 
to incorporate this pentapeptide. Fruit juices contribute to about 60% of the consumed beverages 
in the U.S. However, the stability of the pentapeptide in beverages can be a problem due to 
possible interactions with other components. Nano-encapsulation is a novel and promising 
technique that can be used to deliver bioactive ingredients into food systems. This study involves 
the use of a nano-encapsulating technique to protect the bioactive pentapeptide, incorporating the 
encapsulated pentapeptide into apple juice (model system), and testing for the stability of the 
peptide. The null hypothesis of the study: The Nano-encapsulated pentapeptide shall degrade 
over time when incorporated in apple juice and the alternate hypothesis that the Nano-
encapsulated pentapeptide incorporated apple juice shall be stable over a storage period of 6 
months or more. The specific objectives of this research were to: (1) prepare nanoparticles using 
polylactic-co-glycolic acid (PLGA) to encapsulate the rice bran pentapeptide, (2) incorporate the 
encapsulated pentapeptide into apple juice, (3) evaluate the stability of incorporated pentapeptide 
at 4◦C for 6 months. Nanoparticles that can deliver three different concentrations (200/ 400/and 
600 µg/ml) of pentapeptide were prepared, and the particle size were measured using a laser 
particle size analyzer. Apple juice containing nanoparticles (loaded with pentapeptide) was ultra-
centrifuged to separate nanoparticles, and the supernatant was analyzed by high performance 
 
 
 liquid chromatography (HPLC) C18 column reverse phase (RP) to test the stability of 
pentapeptide. Physical properties of the apple juice were studied which included the evaluation 
of color, microbial count total, acidity (pH), and soluble solid (TSS) during storage period of 60 
days. A particle size ranging from 81 to 83 nm was observed, and the results indicated that there 
were no significant changes in the size over the storage period (0 – 60 days). There was no 
microbial growth observed in the prepared apple juice samples. Total Soluble Solids content was 
11.0 ºBrix for the controls and 31.0 ºBrix for the Nano-encapsulated pentapeptide. The stability 
of pentapeptide at prepared concentrations: 200, 400 and 600µg/ml in water at pH of 3.7 at 0th 
day was: 200ug/mL – 87 %, 400ug/mL – 97%, 600ug/mL – 91%) and in apple juice was: 
200ug/mL – 96%, 400ug/mL – 98%, 600ug/mL – 94 %. The stability of pentapeptide at 60th day 
in water was: 200ug/mL – 41%, 400ug/mL – 60%, 600ug/mL – 55%, and in apple juice was: 
200ug/mL – 60%, 400ug/mL – 67%, 600ug/mL – 59%. The Nano-encapsulated pentapeptide in 
water at pH of 3.7 and apple juice was stable over the storage period of 60 days, which implies 
that the nanoparticles were effective in protecting the bioactive pentapeptide in the acidic 
environment of apple juice. The PLGA nanoparticles showed a remarkable effect in protecting 
and stabilizing the bioactive compounds (pentapeptide) during the shelf life at 4ºC. Polylactic-
co-glycolic acid nanoparticles can thus be a promising carrier for the bioactive pentapeptide 
when incorporated into a juice medium.  
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 CHAPTER 1 
INTRODUCTION 
The International Markets Bureau (2011) documented in 2010 that fruit and vegetable 
juices are consumed at per capita consumption of about 30.3 liter/ person, and the retail market 
in the United States is 8.8 billion dollars. The US Department of Agriculture documented that 
49% of Americans consume more than one glass (236.6 mL; 8 fluid oz.) of juice daily (Andon et 
al., 1996). The International Markets Bureau (2011) further asserts that consumers are 
increasingly becoming health conscious; therefore, the consumption of fruits and vegetables have 
increased in popularity with a larger proportion of the American population. Since consumers 
have become more health conscious and prefer to purchase 100% fruit juices with no additives, 
the manufacturers have improved the ingredients that are used in fruit juices. Fruit juices can 
offer health benefits, such as reducing the risk of cancers and cardiovascular disease. Some 
common ingredients in fruit juices are water, malic acid, sugar, fiber, and minerals. The 
interactions among native components in fruit juices and bioactive ingredients can be minimized, 
making juices suitable vehicles to incorporate bioactive compounds (peptides and proteins) (Day, 
et al., 2009; Tuorila & Cardello, 2002). Vehicles are food systems that can deliver bioactive 
ingredients so that consumers receive maximum health benefits. Apple juice can be a vehicle to 
incorporate peptides because it is the second most popular juice consumed in the U.S., making 
up 12.5% of total juice consumption preceded only by orange juice 60% of total juice 
consumption. Apple juice is rich in phytochemical compounds, especially flavonoids, and 
phenolic compounds (Boyer and Lui, 2004). Because of these beneficial components in fruit 
juices, apple and orange juices are fortified with calcium citrate malate (CCM) and show high 
calcium absorption from CCM. To mimic the composition of Ca fortified juices, the 
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 concentrations of organic acid and carbohydrate in the test solution were manipulated. Apple 
juice has a high Ca absorption because of high fructose and low organic acid content (Andon et 
al., 1996). Also, orange juice is fortified with 1000 IU vitamin D3/236.6 mL, and the result 
shows more than 150 % increase in the serum 25- hydroxyvitamin D3 [25(OH)D] concentrations 
of adults over a 12-week period. Therefore, vitamin D intake can be increased by orange juice 
modification with vitamin D3 (Biancuzzo et al., 2011). Fruit juices such as apple and orange 
juice can be good vehicles for bioactive ingredients such as proteins, peptides, and vitamins due 
to their efficiency to impart health benefits. 
Bioactive compounds have positive effects on human physiological health beyond their 
nutritional values. Examples of bioactives derived from cereal grains include oatmeal, rice bran, 
wheat bran, and protein rice. Rice bran (RB) is rich in protein; protein makes up approximately 
12-20% of rice bran. A pentapeptide is a protein extracted from RB with a sequence of amino 
acids Glu-Gln-Arg-Pro-Arg (EQRPR), pentapeptide is prepared from heat stablized defatted rice 
bran (HDRB). EQRPR has demonstrated anti-cancer proprerties, and has the potential of being 
used as a drug or incorporated into sutitable food products such as orange juice (Kannan et 
al.,2008). For example, in a study conducted by Khairallah (2011), the stability of RB peptide 
fractions into orange juice environment was investigated for 6 months. The peptide fractions 
showed high stability at 4°C and pH 3.0- 4.5, which indicated that fruit juices can be an 
appropriate food system to incorporate bioactive compounds from rice bran. The pentapeptide 
EQRPR can be incorprated into several food aplications due to its health benefits, disease 
prevention, and higher stability. 
It is likely that the bioactive peptides can interact with the components in juice matrix 
and influence the stability. The interaction between ingredients in fruit juices can initiate 
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 chemical deterioration and changes in flavor and aroma of food products. To overcome this 
problem, the encapsulation technique can be an effective method to protect the bioactive peptide 
and prevent interactions with other compounds (Abhilash, 2010). Encapsulation method can be 
defined as “a process to entrap active agents within a carrier material” (Nedovic et al., 2011). 
The encapsulation technique contains two parts: a core or bioactives and a shell or coating 
materials (Abhilash, 2010), and it is an effective method that can be used to encapsulate the 
bioactive ingredients and impart their health benefits to specific sites of the human body.  
Nano-encapsulation is a promising technique, and can be defined as the formation of 
particles loaded with ingredients in diameters ranging from1-100 nm (Reis et al., 2005). Nano-
encapsulation is used in several areas of the food sector including, food processing, safety, and 
packaging (Garcia et al., 2010). Nanoparticles are solid submicron-sized particles that can carry 
functional food ingredients. Nanoparticles can be synthesized from natural or synthetic polymers 
such as poly d,l-lactide-co-glycolide acid (PLGA) (Janusz et al., 2000). There is a need to 
investigate the stability of the bioactive pentapeptide in product applications since the consumer 
prefers bioactives in food products rather than in drug form.  
The objectives of this study were to: 
1. Prepare nanoparticle to encapsulate pentapeptide and test for stability for 6 months. 
2. Incorporate the pentapeptide containing nanoparticles in apple juice. 
3. Investigate shelf life stability of Nano-encapsulated pentapeptide in apple juice for 6 
months at 4 °C. 
4. Evaluate the physical attributes of apple juice with Nano-encapsulated pentapeptide 
for 6 months.  
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 CHAPTER 2 
LITERATURE REVIEW 
A. Fruit juice consumption in the U.S.  
The International Markets Bureau documented in 2010 that the fruit and vegetable juice 
industry was worth about 8.8 billion dollars in the United States. The International Markets 
Bureau (2011) further asserts that consumers are becoming more health conscious. On an 
average, about 12.3% of Americans consume apple juice, 60% orange juice, 9.6% mixed fruits, 
3.2% cranberry, and 3.8% grape juice (International Markets Bureau, 2011). Consumers’ 
perception of foods has changed from using food to satisfy hunger to seeing food as a tool for a 
healthy lifestyle. Flavors, aroma, price, and health benefits are the primary attributes that can 
attract consumers to purchase a food product (Urala and Lahteenmaki, 2007). Functional food 
can be defined as a food with “added technologically developed ingredients with specific health 
benefits” (Siro et al., 2008). The functional food market has changed to meet consumer demands, 
demonstrated by the invention of staple foods and beverages. Siro et al., (2008) reported that the 
United States has the largest market segments followed by Europe and Japan. American 
consumers contribute over 90% of the total sales. Functional food and beverages are new tools to 
receive additional health benefits (Siegrist et al., 2008). The top 10 functional foods were 
investigated in a study conducted by Sloan (2010); it was found that the traditional foods, such as 
whole grains, topped the food choices list followed by fresh fruits and healthy snacks. People 
consume more natural fruit drinks since they are looking for products that are enriched in 
antioxidants, such as polyphenolics and flavonoids. Because consumers prefer juices that are rich 
in nutrients, low calorie, and have no added sugars, they will appreciate the idea of functional 
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 foods. Therefore, food manufacturers focus on formulating improved, functional beverages to 
target physiological functions and attract consumers.  
B. Suitability of vehicles for nutraceuticals and functional foods.  
The health benefits of 100% fruit juices, such as low sugar and zero additives account for 
the increasing rate of consumption (Pollack, et al., 2003). Gerhauser (2008) reportes “several 
lines of evidence suggesting that apples and apple products possess a wide range of biological 
activities which may contribute to health beneficial effects against cardiovascular disease, 
asthma and pulmonary dysfunction, diabetes, obesity, and cancer”. In a study done by Duffey 
and Popkin (2006) on American adults, it was found that 20% of daily calories intake can be 
from beverages. Also, fruit juices are simple systems; for example, apple juice, mainly consisting 
of water, malic acid, sugar, fiber, and minerals; therefore, the possible interactions during the 
handling process or physical damage, which may initiate chemical and microbial spoilage can be 
monitored (Day et al., 2009; Tuorila and Cardello, 2002) by pasteurization of fruit juices 
(Polydera et al., 2003). For example, omega- 3 fatty acids, plant sterols, vitamins, and minerals 
have been used to fortify orange juice, such as Tropicana (Devaraj et al., 2004). Minute Maid is 
another example of a beverage that is enriched with essential vitamins A, D, E, and B and 
minerals including zinc, calcium, magnesium, selenium, chromium, and frauctooligosaccharide 
(Tangpricha et al., 2003; Renuka et al., 2009). Apple juice a rich source of phytochemical 
compounds, especially  phenolics. Apple juice is ranked as having the second highest amount of 
antioxidant and phenolics concentrations in comparison to other fruit juices in the U.S. Also, it 
has a high level of free phenolics (Boyer and Luis, 2004). Table 1 shows the average nutrients in 
apple juice and table 2 shows the polyphenol content in apple juice. The six classes of 
polyphenolic compounds in apple juice are: anthocyanins, flavonol glycosides, phenolic acids 
5 
 
 (chlorogenic and p-coumaroylquinic acids) dihydrochalcones (phloretin glucoside and 
xyloglucoside), catechin (epicatechin, and procyanidins), and the procyanidins. A moderate 
amount of carbohydrate in the form of natural fructose and glucose are present in apple juice 
(Miller et al., 1996). These compounds can potentially reduce oxidative stress and regulate the 
immune system by reducing reactive oxygen species (ROS) (Boyer and Luis, 2004). Apple juice 
contains ascorbic acid (vitamin C), which can prevent degradation and oxidation of polyphenol 
compounds. Also, vitamin C can prevent a Millard reaction and maintain the flavor of apple 
juice, while also contributing to reduce the risk of cancers and cardiovascular disease (Chen and 
Sato, 1995). Apple juice is also rich in vitamin B complex including riboflavin, thiamin, and 
pyridoxine, which act as co-factors of enzymes involved in the functions in the body. 
Furthermore, apple juice contains a high amount of calcium, potassium, phosphorus, soluble 
fiber (pectin), and a low amount of sodium. Calcium is important for bone functions and blood 
clotting. Potassium is a major principle ion, which can maintain fluid and fluid electrolytic 
balance, maintain steady heart beat and intracellular pressure, and assist proteins metabolism. 
Apple juice can reduce sodium level in tissues because of high potassium content. Phosphorus 
plays a vital role in cell membrane structure and metabolic processes. Consuming apple juice can 
help detoxify liver, prevent gallstones, improve gut health, boost the immune system, and 
decrease the risk of diabetes (Jalili et al., 2007). Since the diet is responsible for 80% of disease 
protection (Schaefer et al., 2005), consuming fruit juices that are high in phytochemical 
compounds and vitamins and minerals can promote health. Therefore, apple juice can be used as 
a vehicle to incorporate bioactives and peptides.  
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 C. Vehicles to incorporate nutraceuticals, flavors, nutrients, and proteins.  
Bioactive compounds can provide possible positive effects on human physiological 
health that transcend those offered by basic nutritional functions of food. Therefore, the 
constituents and derivatives of proteins and peptides play a potenitial role in treating as well as 
preventing diseases. The bioactive compounds, such as proteins and peptides, are known to 
impart several biological functions, such as anti-cancer, anti-obesity, anti-angiogenic, anti-
hypertensive, antioxidants hypocholesterolemic, and immunomodulatory functions (Kannan et 
al., 2008, Rayaprolu et al., 2012). Soy and whey are rich sources of proteins that can produce 
bioactive compounds (Rayaprolu et al., 2012). Oryzatensin is derived from rice albumin and 
demonstrates an immunostimulatory role. Also, soy bean proteolytic hydrolysis by alcalase and 
Proteinase S enzymes derived peptides have anticancer, antihypertensive and antioxidative 
effects (Kannan et al., 2008, Rayaprolu et al 2012). Oatmeal, rice bran, cereal products, milk 
proteins (Wildman, 2007), fruit beverages, and nanomaterials are also good vehicles to deliver 
bioactive compounds. Preserving the active ingredients, bioavailability assures nutraceutical 
products’ effectiveness in reducing the risk of diseases. Therefore, food manufacturers offer 
vehicles to deliver physiological health benefits to specific organisms. For example, these 
bioactive molecules acetylcholine, histamine, cortisone/hydrocortisone, and phenoxyacetic acids 
have gone through synthetic modifications of their parent compounds to get a specific activity 
(Kang et al., 2013). The nanoparticles were used to improve nuclear targeting efficiency in 
HepG2. “A 20 nm diameter modified gold particle by shell of bovine serum albumin (BSA) 
conjugated to various cellular targeting peptides” (Tkachenko et al., 2003). The results indicated 
that “Nanoparticles carrying peptides had a greater propensity for nuclear targeting than any 
other single peptide explored” (Tkachenko et al., 2003). Also, these vehicles can maintain their 
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 active molecular form until consumption (Chen et al., 2006). Since food proteins are safe, have 
high nutritional values, and have emulsification properties, they are widely used as vehicles for 
functional foods. For example, milk proteins, such as casein micelles, are ideal vehicles to 
transport micronutrients such as calcium and phosphate. Also, casein micelles can transport the 
components of the immune system, such as lactoferrin and immunoglobulin, and building blocks 
such as amino acids. For instance, a variety of small molecules can be bound by bovine albumin 
serum and B-lactoglobulin (Livney, 2010). Milk proteins are widely used because they are safe, 
inexpensive, natural, have high nutritional values, and contain a variety of structural and 
functionality attributes. Whey protein is a good vehicle to incorporate bioactives. For example, 
B- lactoglobulin is a whey protein found in cows’ milk that can form nanoparticles linking the 
hydrophobic molecules. (−) Epigallocatechin-3-gallate EGCG is a water soluble catechin found 
in green tea and has a potential to reduce cancers, also neurodegenerative and cardiovascular 
disease. However, EGCG is sensitive to oxidation and its degradation can be affected by 
temperature, pH, and oxygen concentration. Also, EGCG can change the color of green tea to 
yellow or brown when it is degraded. Therefore, the B- lactogglobulin forms nanoparticles to 
encapsulate EGCG. This effectively protects against oxidation, and prevents unpleasant flavor 
and change in color (Shpigelman et al., 2010). 
Zimet et al. (2011) found that nano-vehicles can be used to deliver hydrophobic 
nutraceuticals such as omega-3 fatty acid into beverages. Omega-3 fatty acids are 
polyunsaturated fatty acids such as docosahexaenoic acid (DHA), an important nutraceutical 
lipid which is known to provide protection against cardiovascular and other diseases. Since DHA 
is sensitive to oxidation, it was encapsulated by casein nanoparticles for a successful delivery 
(Zimet et al., 2011). Also, milk proteins are capable of interacting with other biopolymers, 
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 stabilizing emulsions, binding hydrophobic molecules, forming gel, and preventing oxidation. 
Casein micelles can reassemble in vitro, contributing functional properties while preventing 
oxidation, off flavor, and odor.  
In the Garcia-Nebot et al (2009) study, caseinophosphopeptides (CPPs) were used as a 
vehicle for micronutrients such as iron (Fe). The CPPs were derived from casein by enzymatic 
hydrolysis. CPPs were added to fruit beverages such as grape, orange, and apricot puree. The 
Garcia-Nebot study concludes that the CPPs served as a good delivery system and contributed to 
a decrease in Fe deficiency and increased the bioavailability of minerals. Fruit beverages are 
suitable media for nutrients because of high nutrient solubility and low mineral absorption 
inhibitors concentrations. Nano vehicles which are part of nanotechnology are an excellent 
delivery system for bioatives such as peptides and nutrients. Also, fruit juices are a good food 
system for proteins and peptides.  
D.  Examples of peptides and proteins incorporated into beverages. 
Beverages are ideal vehicles to incorporate nutraceuticals and bioactive ingredients, such 
as proteins, vitamins, minerals, and dietary fiber (Sharma et al., 1997). Sharma et al. (1997) 
formulated protein-fortified-fruit-based-beverages, such as orange juice, by adding whey protein, 
guar gum, sucrose, calcium lactate, citric acid, natural flavor, and color. Clarisoy is a plant 
protein isolate product that was developed by the Canadian company Burcon NutraScience. It is 
highly soluble, has low viscosity, heat-stable, transparent, has no off-flavor or color change, and 
has high stability in acidic conditions (2.5 - 4.2 pH). Therefore, it is a suitable protein to use in 
acidic beverages such as orange juice. Incorporation of soy protein isolates in acidic beverages 
has been demonstrated to have advantages in preventing coronary heart disease, osteoporosis, 
and some types of cancers. Soy protein isolates are also suitable for vegetarians or those that 
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 have milk or dairy allergies (Segall, 2009). Also, fruit beverages, such as grape, orange, and 
apricot puree, were fortified with Caseinophosphopeptides (CPPs) to decrease Fe deficiency and 
increase the bioavailability of minerals.  
Fruit beverages can also be good vehicles for peptides. Rice bran peptide fractions are 
water soluble; therefore, they are easily incorporated into beverages. Rice bran (RB) peptide 
fractions demonstrated anti-cancer, anti-obesity, and anti-Alzheimer properties (Kannan et al 
2008, 2009 and 2011). Khairallah (2011) conducted a study in investigating the stability of rice 
bran peptide fractions incorporated into orange juice at pH 7.2 and 3.5, and 4°C for 42 days. The 
results indicated higher stability of the fractions at pH 3.5 in orange juice for 42 days than at pH 
7.2, and the amount of peptide fractions decreased after 21 days. The color, pH, and vitamin C 
content of orange juice were stable.  
E. Problems associated with incorporation of proteins and peptides into beverages. 
A simple way to develop a novel functional food is incorporation of bioactive compounds 
such as, proteins, peptides, vitamins, and minerals in delivery systems. These bioactive 
compounds can possess health benefits. However, bioactive compounds’ activity and health 
benefits can be limited due to instability during storage and processing such as pH, light, oxygen. 
Also, the interactions due to the presence of enzymes and other nutrients can affect the stability 
of bioactives (Chen et al., 2005). In Shimonia’s (2004) study, the soy isoflavones shows 
browning activity due to genistein loss during storage at room temperature for more than two 
years. The main reasons for the addition of bioactive compounds in food system are to improve 
nutrition, texture, appearance, and flavor; however, the stability of food products can be affected 
by the addition of bioactive compounds. The chemical treatments during processing such as 
alkaline, acidic treatments can have an impact on stability of bioactives. Chemical modifications 
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 (acylation, glycosylation, phosphorylation, reductive alkylation, succinylation, and 
lipophilization), have an impact on improved functionality. However, these chemical 
modifications can cause negative effects because of the possibility of some residual chemicals; 
therefore, food industry practices the chemical modifications with caution (Korhonen et al., 
2003). Heat treatment which is the oldest and the most common preservative method is used in 
the food industry. The bioactivity can be reduced due to the exposure of high temperature (60-
90Cº), which might denature the protein. For example, whey proteins retained their bioactivity 
when pasteurized at a standard temperature 72Cº for 15 seconds. Furthermore, heat treatment can 
induce a Millard reaction when lysine residues in proteins interact with reducing sugar in the 
food matrix. Ultra high pressure is used in food products under isostatic pressure at room 
temperature, which may cause conformational changes on proteins (Korhonen et al., 2003). The 
physical and chemical characteristics of the food products can have an impact on nutrition.  
 Most epidemiological studies suggest increasing the intake of fruits and vegetables to 
reduce the risk of a number of chronic diseases (Nicoli et al.1999). Fruit and vegetables provide 
multiple phytochemical, fibers, and bioactive compounds, which possess antioxidant activity and 
can prevent cellular damage in vitro. However, people rarely consume fruit and vegetables in 
their raw state, and they need to be proceeded before consumption due to safety and economic 
issues. In general preservatives are known to reduce naturally occurring antioxidant compounds 
in food. The recent approach to improve the antioxidant content in fruits and vegetables is to 
minimize processing damage, and increase the shelf life. However, the addition of antioxidants 
does not offer an effect on human health that can be achieved from naturally occurring 
antioxidants (Nicoli et al.1999). Nicoli et al. (1999) reported that the antioxidant amounts 
declined in thermally treated fruits and vegetables, which resulted in lower post-consumption 
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 intake of ascorbic acid and polyphenols in humans. A study conducted by Khairallah (2011) on 
testing the stability of peptide fractions in orange juice indicated that the peptide fractions were 
stable for 42 days. Peptide fractions in the orange juice reached zero after 42 days, which implies 
that the acidic environment of orange juice affect the stability of peptide fractions. In Patras et 
al., (2011) study, on the stability of strawberry juice during storage, the results indicated that 
antioxidant capacity of the juice changed when stored for more than 28 days. Lightness value (L) 
of the juice decreased considerably when stored for more than 28 days and at 15° C. It was also 
observed that kinetics (k) constantly increased with increase in temperature. Rate of reaction of 
(k) for anthocyanins changed from 0.95x10−2 day−1 to 1.71×10−2 day−1 at 4 °C 15 °C. Thus, the 
overall stability was affected. The stability is the main challenge in incorporating bioactive 
compounds into beverages. This challenge can potentially decrease the health benefits and 
physiological functions of bioactive compounds. Food manufacturers have invented new 
techniques to encounter these challenges, such as encapsulation and Nano-encapsulation 
techniques.  
F. Processes of overcoming the issues associated with incorporation of bioactives.  
Encapsulation is defined as the process employed to entrap the substance using a 
secondary substance. Encapsulation also has been used in the food industry to coat bioactive 
ingredients creating new food structures with unique functionalities (Sekhon, 2010). 
Encapsulation composed of two parts: a core or coated material and a shell or coating material 
(Abhilash, 2010). Bioactive substances are packaged by secondary materials, which are known 
as encapsulants, to form microcapsulates. These encapsulants, or shells, act as preservative 
coatings of the functional ingredients to avoid degradation by undesirable chemical reactions, 
which might influence human health or the flavor, color, and aroma of food products.  
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 Encapsulation promotes the transport of bioactive molecules, such as minerals, 
antioxidants, vitamins, fatty acids, and phytosterols including molecules like lycopene and lutein. 
Proteins and polysaccharides also have been used to encapsulate, deliver, and protect lipophilic 
components such as u-3 rich oils, conjugated linoleic acid (CLA) (Matalanis et al., 2011). 
Encapsulation also transports living cells, such as probiotics, into foods (Smith and Charter, 
2010). Also, it increases the stability, as it prolongs shelf life, prevents interactions of flavors 
with other compounds and off flavor, facilitates handling processes, and reduces vitamin loss in 
functional ingredients (Gibbs and Kermasha, 1999). Encapsulation can carry the functional 
ingredient to the appropriate site in the body or organism, maintain the functional materials in 
their active state during processing and storage by protecting them from chemical and 
biochemical degradation, and control the release rate under certain conditions such as pH, 
temperature, and ionic strength (Weiss at al., 2006). Encapsulation is an effective delivery 
system that can maintain the stability and bioavailability of bioactive compounds into fruit 
juices. 
Several techniques can be applied to encapsulate bioactives, such as spray-dry chilling or 
cooling, extrusion, and emulsification. Spray drying is widely employed for flavors and 
dehydration of materials such as powdered milk. It is an economical method and does not require 
specialized equipment. Spray drying can be designed to the required capacity and the process is 
very rapid. There is various available spray drying designs for each specification of products 
(Leak, 1989). Spray drying can be employed with either heat sensitive or heat resistant products. 
However, the main two disadvantages of spray drying are that the equipment is very bulky and 
the ancillary equipment is expensive. The overall thermal efficiency is low, as the large volumes 
of heated air pass through the chamber without contacting a particle, thus not contributing 
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 directly to the drying (Leak, 1989). Spray chilling or spray cooling is another employed method 
of encapsulation. In spray cooling, vegetable oil is usually used as an outer material, while spray 
chilling uses fractionated or hydrogenated vegetable oil. Spray cooling requires special handling 
and storage conditions (Gibbs et al., 1999). Extrusion is a method of encapsulation, which is 
primarily applied to visible flavor pieces, colors and vitamin C (Lebovka et al., 2011). Extrusion 
can provide thinner walls by increasing the pressure with low operation cost. Extrusion has 
flexibility in the design of the product. The main disadvantages of this method are the low speed 
of extrusion and low production, while cost of tools is high. The extrusion process has high 
amount of wastes (Gibbs et al., 1999). However, liposomes, nanoliposomes, and nanoparticles 
are the new encapsulation techniques in food industry. Liposomes are a superior example of 
encapsulation. Liposomes and nanoliposmes are made of phospholipid bilayers, and hence they 
contain both polar and nonpolar regions. “Liposomes are closed, continuous, vesicular structures 
composed mainly of phospholipid layers” (Mozafari et al., 2008). The hydrophobic groups 
interact with hydrophobic groups that are in other lipid molecules, whereas the hydrophilic 
groups of the lipids will align the aqueous phase to form the phospholipids or liposomes outer 
layers. The lipid sheet will be folded into a spherical shape and will form a stable capsule 
because there are no interactions between water and lipids. Liposomes are mainly used to 
encapsulate flavor agents, and range from a few nanometers to microns. The liposome 
encapsulation method is used in the cheese-making application to decrease the ripening time and 
increase shelf life. Nanoliposomes are liposomes’ nanometric form, and they can act as 
nanocarriers to deliver bioactives. Egg, soy, and milk economically produce insoluble 
phospholipids in lecithin. These proteins can be used to form liposomes and nanoliposomes. 
They contribute greatly to human health (Gibbs et al., 1999). Takahashi et al (2009) conducted a 
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 study in examining the feasibility of using liposomes to encapsulate curcuma longa L. Curcuma 
longa L. The main component in rhizomes, and Curcuma longa L has demonstrated anticancer 
properties and other activities. Liposomes were used to encapsulate curcuma longa L to protect 
and deliver the bioactives. The study indicated that adsorption of curcuma longa L in the GI and 
the antioxidant activity of plasma were enhanced by using liposomes. However, large molecules 
such as proteins permeate very slowly through the liposome bilayer, while small hydrophilic 
molecules permeate more quickly. If large molecules are soluble in the lipids that form the 
outside of liposomes, then they can permeate through a liposome bilayer (Gibbs et al., 1999). 
Liposome encapsulation requires restricted conditions to maintain their stability. For example, 
freshly prepared lipids and solvents, averting exposure to oxygen and extreme temperature are 
required for increasing stability. Using appropriate handling conditions and avoiding charge 
neutralization by adding metal chelators are also required. The liposomes will aggregate because 
of van der Waals interactions; therefore, the aggregation can be reduced by the addition of 
phosphatidic acid (Anal&Singh, 2007). 
 Recently a new technology has emerged in encapsulating to deliver bioactive such as 
nanotechnology. Nanotechnology “involves creating and manipulation of organic and inorganic 
matter at the nanscale” (Luykx, et al., 2008). Nanotechnology provides potential benefits for 
both producers and consumers. It improves flavor, color, and all other properties of food 
products. Nano-encapsulation defined as “forming particles loaded with ingredients in diameters 
of 100 nm” (Reis et al., 2005). Also Weiss et al., (2006) defined Nano-encapsulation as a 
technique that is used to alter and coat biological and non-biological structures that are less than 
100 nm in size. Furthermore, nanoparticles have shown increased shelf life stability. Nano-
encapsulation is more efficient in comparison to liposomes and nanoliposomes (Hans and 
15 
 
 Lowman, 2002). Nano-encapsulation is involved in several areas of the food sector, such as food 
processing, safety, and packaging (Garcia et al., 2010). Nano-encapsulation is a powerful 
technology, which can tolerate the properties and functionalities of bioactives, and potentially 
lead to improving the stability and delivery of bioactive ingredients. Functional ingredients 
including, vitamins, flavorings, colorings, and antioxidants are varied in their physical and 
molecular properties. They are never used in their pure forms; therefore, a delivery system is 
required (Fakruddin et al., 2012). For instance, the most important groups of natural pigments 
are carotenoids, which contribute approximately 70 % of vitamin A to the human diet. 
Carotenoids provide protection against cancers and cardiovascular diseases; however, they are 
insoluble in water which potentially reduces its incorporation in foods. In a study conducted by 
Yuan et al., (2008) ‘beta carotenoids were incorporated into micro emulsion prepared by using a 
series of polyoxythylene sorbitan esters of fatty acids as emulsifiers”. The stability of beta 
carotenoids was investigated during storage for four weeks at 4Cº. The results indicated that beta 
carotenoids were gradually degraded and the loss was only 14% by the end of the study. 
 In addition to increased stability, the nanostructure has been used in food industry with 
claims that it provides better texture and consistency such as low fat nanostructure mayonnaise 
and ice cream. They were produced as healthy alternatives for consumers by providing a creamy 
texture as full fat products (Chaudhry et al., 2008). Nanoparticles are also used to encapsulate 
broad ranges of proteins such as tetanus toxoid, lysozyme, and insulin. In a study conducted by 
Bilati et al (2005), poly (D, L-lactic acid) and poly (D, L-lactic-co-glycolic acid) were used to 
form nanoparticles to encapsulate tetanus toxoid, lysozyme, and insulin. The results showed that 
the encapsulation improved protein loading and stability. In another study gold nanoparticles 
have been used to encapsulate a pentapeptide (Cys, Ala, Leu, Asp, and Asp) CALNN and it 
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 formed extremely stable nanoparticles in water (Lévy, et al., 2004). Nanotechnology can 
contribute a high quality system for bioactive ingredients and nutraceuticals such as proteins and 
peptides. 
G.  Nano-encapsulation of bioactives.  
Nanoparticles have potential in overcoming issues associated with the incorporation of 
peptides into beverages. Nano-encapsulation has been used in several applications in food 
industry including manufacture and processing (Luykx, et al., 2008). Small particle size makes 
nanoparticles more effective than other encapsulation approaches such as the use of liposomes. 
The small particle size, chemical composition, surface structure, and toxicological properties 
give nanoparticles their unique features (Luykx, et al., 2008). Furthermore, the small particle size 
provides advantages, such as ease in ingesting particles into the circulatory system. It also has 
large surface areas, which can provide different physical and chemical effects on food products. 
Subsequently, various chemical interactions can be prevented (Garcia et al., 2010). In the nano 
delivery system, the nutraceuticals, bioactive peptides, and antioxidants can be absorbed, 
incorporated, and dispersed. The Nano delivery system can prevent nutraceutical degradation, 
and can enhance the stability. Thus, the bioavailability and delivery of bioactive peptides and 
nutraceuticals to specific cells or tissues in the body can be increased.  
Sekhon, (2010) defined the nanofoods as “The term ‘nanofood’ describes food that has 
been cultivated, produced, processed or packaged using nanotechnology techniques or tools, or 
to which manufactured nanomaterials have been added”. Nano-food products mostly use 
engineered nanomaterials (ENMs) that include three categories: inorganic, organic, and surface-
functionalized nanomaterials (Sekhon, 2010).  
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 In-organic nanomaterials can be used in food additives and food packaging applications. 
The ENMs in these applications include transition metals such as silver and iron, non-metal such 
as selenium and silicates, and alkali metals such as calcium and magnesium. Nanosilver is used 
in several food applications such as functional foods and water. Functional foods and water 
provide antimicrobial, antioxidant, and supplements. Nanoselenium is also being used in green 
tea as a food additive and promotes health due to increasing selenium uptake. Nanocalcuim, 
nanomagnesium salts, and nanoiron are used as health supplements (Sekhon, 2010). 
Organic nanomaterials are used in food applications as food additives or health 
supplements. These materials include benzoic, citric, and ascorbic acids; vitamins A and E; 
isoflavones; omega-3 fatty acid; lutein; and beta-carotein. These organic nanomaterials can 
increase the uptake and absorption of bioactive compounds and, hence, enhance bioavailability 
(Sekhon, 2010). Third, surface functionalized nanomaterials display a specific functionality 
when they are added to the matrix like antimicrobial and preservative activity. Functionalized 
ENMs can offer mechanical strength or a barrier against gas and volatile compounds movement 
and moisture when binding to the matrix. Nanoclay metal is a natural nanomaterial that is 
organically modified and used in food packaging to enhance gas properties. Furthermore, 
functionalized nanomaterials can deliver bioactive compounds and nutrients. The natural nano- 
vehicle casein missiles are used to deliver hydrophobic bioactive compounds. A novel 
encapsulation to deliver heat-sensitive bioactive compounds such as probiotics is developed. 
Delivery of hydrophobic nutraceuticals through B-lactoglobulin–pectin nanocomplexes in clear 
acid beverages is anther innovation of nanotechnology (Sekhon, 2010).  
Sekhon (2010) reports that word ‘nano’ comes from the Greek for dwarf, and one 
nanometer is about 60,000 times smaller than a human hair in diameter or the size of a virus. It is 
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 important to note that nanoparticles are very small, less than 100nm (Sekhon, 2010). Food 
nanotechnology potentials are unlimited and have a positive impact on science of food such as 
new food product invention in texture, taste, and storage stability. It is reported by 
nanotechnology analyst that 150-600 nano-foods are available in the market (Sekhon, 2010).  
Nanoparticles deliver bioactive ingredients to the desirable site of function, provide protection 
during processing or from chemical or biochemical degradation, and increase the capability of 
controlling the release of bioactives in specific environmental conditions, such as pH, ionic 
strength, etc. (Weiss et al., 2006). The small nanoparticle size enhances adhesive forces, 
prolongs transit time of bioactives in the gastrointestinal tract and increase bioavailability (Luykx 
et al., 2008). The small nanoparticle size has different bio-distribution from organ to organ; 
therefore, it is necessary to control the particle size for each application (Cheng, 2007). The 
application of nano-encapsulation process has various advantages. It is responsible in making 
food processing faster and more efficient. Nano-encapsulation improves stability of bioactive 
compounds, especially during storage and processing to avoid any undesirable effects with the 
food matrix, and controls the release (Luykx et al., 2008).  
Proteins, lipids, polysaccharides, and polymeric networks based are the types of 
nanoparticles that exist in food applications. Food grade polymers (copolymers) are extensively 
used in controlled release carriers for protein preparation due to their biodegradability and 
compatibility, especially those that are derived from poly (lactic acid) and poly (glycolic acid) 
such as a biodegradable copolymer poly D, L-lactide-co-glycolide acid (PLGA). PLGA is an 
aliphatic polyester polymer (Luykx et al., 2008). PLGA polymer can be degraded into two 
biocompatible by-products, lactic and glycolic acids, through hydrolytic cleavage of ester bonds. 
The copolymer PLGA is excreted from the body as carbon dioxide and water. The PLGA 
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 degradation rate is essential to regulate the release rate of the coated ingredients based on 
molecular weight and hydrophobicity of PLGA. PLGA biopolymer is rich in glycolic acid and 
has a high degradation rate. The degradation rate increases as the molecular weight decreases 
due to the carboxyl groups. The acid-catalyzed degradation accelerates due to the carboxyl 
groups that are toward the end of PLGA structure. The hydrophobicity of PLGA biopolymer and 
acid catalysis potentially affect the stability of proteins and peptides (Park et al., 2002). PLGA 
was used to encapsulate haloperidol, which is a drug to treat schizophrenia. It showed great 
influence on haloperidol, controlling release and stability. To protect the integrity during 
formulation and delivery, PLGA nanoparticle was used to load and dispense insulin molecule 
(Kumari et al., 2010). In Ravichandran’s et al., (2011) study, PLGA nanoparticles have been 
used to encapsulate phenolics (benzoic acid) to prevent microbial growth in meat systems. Nano-
encapsulated phenolics were effective in preserving the meat for a longer storage period. In 
Ganea’s et al., (2010) study, a lipid soluble benzoquinone-based phytochemical (Thymoquinone) 
was encapsulated by poly (D,L lactide-co- glycolide) PLGA nanoparticles to protect antioxidant 
and anticancer activities. In another study, the poly-D, L-lactide (PLA) has been used to 
encapsulate the antioxidant (quercitrin), and it has the potential to deliver the antioxidant 
(quercitrin) (Kumari et al., 2011). 
Using polymers such PLGA in forming nanoparticles is a great promise in delivering 
functional ingredients such as pentapeptide because it has unique characteristics in 
encapsulating, loading, and releasing. The outcome of nanoparticle materials can be controlled 
because this polymer can be processed with numerous functionalities and properties (Schubert et 
al., 2010). PLGA polymers have the most favorable degradation properties and have shown 
potential immense in delivering proteins and peptides. The degradation properties of this 
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 polymer can be tuned by dominating the molecular weight, lactide and glycolide ratio, and 
concentrations of peptides (Makadia, et al., 2011). Degree of PLGA crystallinity directly 
influences the biodegradation rate. For instant, when the PLA is co-polymerized with crystalline 
PGA, the degree of PLGA crystallinity is reduced. Thus, the hydration and hydrolysis rate 
increase. Makadia, et al., (2011) reported that the ratio of 50:50 PLA/PGA showed the fastest 
degradation rate. PLGA polymer has been used as an ideal delivery carrier in delivering protein 
and peptides because of its biodegradability, compatibility, and the ease of it to be elaborated 
with desired characteristics and functionalities (Singh, et al., 2009).  
Other polymers such as polylactic acid PLA polymer were used in several encapsulation 
applications. A steroid hormone progesterone C-21, which involves in the menstrual cycle and 
pregnancy, was loaded in PLA–PEG–PLA nanoparticles. It shows that the PLA nanoparticles 
encapsulated effectively with 70±5%, while PEG increased release in vitro (Kumari et al., 2010). 
Furthermore, BSA was encapsulated by a tadpole-shaped polymer mono (6-(2-aminoethyl) 
amino-6- deoxy)-cyclodextrin-PLA (CDen-PLA). It showed 71.6% encapsulation efficiency and 
high stability after release of BSA from nanoparticles (Kumari et al., 2010). Poly-caprolactone 
PCL is a polymer that can be degraded under physiological conditions by hydrolysis of its ester 
linkages. The copolymeric nanospheres containing taxol Polyethylene glycol–PCL are reported 
as promising anticancer properties owning to their efficiency of loading drug by 20%. Also, 
copolymeric nanospheres systems such as mPEG/PCL can be a great delivery system ad can also 
possess anticancer properties (Kumari et al., 2010). 
H. Nano-encapsulation of pentapeptide in apple juice.  
Peptides provide unique features more than proteins and lipids; thus, they become 
attractive for therapeutic delivery applications. Most of anticancer agents can lead to systemic 
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 toxicity and adverse effect because they cannot distinguish between cancerous and normal cells; 
therefore, decreasing the drug dose is required (Sinha et al., 2006). Furthermore, those anticancer 
agents are not economical and result undesirable toxicity because large quantity are needed for 
rapid elimination and widespread distribution into targeted organs and tissues. Low specificity of 
some anticancer drugs leads to harmful effects on healthy cells and tissues (Sinha et al., 2006). 
Peptides afford high valency due to their small size, which minimizes the radius of the resulting 
peptides-nanoparticles conjugate. The immunogenicity in vivo can be also reduced by the small 
size of peptides. Peptides can be easily sequenced and synthesized in the laboratory; therefore, 
they are economical. Peptides can be very specific and bind with high affinity to their cognate 
receptors, since they are naturally occurring from protein precursors. Furthermore, 
multifunctional groups of peptides can be incorporated into the nanoparticles (NPS) to produce a 
‘value-added’ material that serves multiple purposes in one NP (Delehanty et al., 2010). Peptides 
are very attractive and useful molecules for the evolution of NPs. 
Biologically active peptides can be derived from dietary protein with several 
physyological functions. Rice bran (RB) can be a good example of dietary protein that is 
enzymatically hydrolyzed to release the bioactives. Rice bran has significant amounts of protein 
consisting of approximately 12-20 %. Pure peptide (pentapeptide) that is derived from heat-
stablized deffated rice bran has been demonstrated to have anti-cancer properties. It inhibits 
colon cancer cells by 84%, breast cancer cells by 80%, liver cancer cells by 84%, and lung 
cancer cells by 69% (Kannan et al., 2010). Rice bran constitutes 10% of the rough rice grain and 
is an excellent source of vitamin E and B (Parrado et al., 2008). Rice bran is produced by 
removing the pericarp and germ from the outer layer of brown rice. Abrasively milling removes 
the brown outer layer and results in white rice grain (Saunders, 1990). Hemicelluloses and 
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 glucofractuctans are fibers that constitute rice bran in addition to ash, enzymes, vitamins, 
antioxidants, and protein (Ali et al., 2010). According to Herbst and Herbst (2007) rice bran 
peptides can also lower cholesterol levels.  
Kannan et al (2008) conducted a study to investgate the antidisease properties such as 
liver and colon cancer of rice bran peptides. Kannan et al (2008) generated bioactive peptides 
through enzymatic hydrolysis of rice bran. The peptides were fractionated into > 50, 10-50, and 
<5 KDa sizes and tested for anticancer properties. The results indicate that the bioactive peptides 
<5 and 5-10 KDa sized fractions supressesd colon cancer cells (Caco-2) growth by 80%. The <5 
KDa fractions inhibited liver cancer cell (HepG2) growth by 50%. Bioactive peptides can be 
readily prepared, however, maintaining bioactivity and stability of peptides are two main 
challenges facing the food industry. Nano-encapsulation of these bioactives can potentially 
maintain the stability and prevent degration of bioactive peptides during storage period 
(Allémann et al., 1998). 
I. Shelf life stability of Nano-encapsulated pentapeptide in apple juice. 
A wide variety of food products are manufactured in a location that is far away from the 
places where they are consumed. Current manufacturing and distribution practices may delay the 
consumption of food products for a few weeks or months from production. Hence, food products 
may undergo a series of chemical reactions which may cause change in desirable flavor, aroma, 
appearance and texture of food products (Kepplinger et al., 2001). The overall quality of food 
products will be affected and subsequently the consumer acceptance and purchase of food 
products will decrease and may cause food product wastage. The deterioration of food products’ 
quality will significantly influence the profits of a company.  
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 Typically, manufactures attempt to enhance the quality of food products by adding 
preservative agents (Kepplinger et al., 2001). However, the addition of preservative agents may 
lead to problems including initiation of additional chemical reactions with other components in 
the food matrix and producing change in food product characteristics (Kepplinger et al., 2001). 
Consumers demand high quality food products with less chemical additives and hence, 
manufactures look for alternatives from natural sources to enhance food quality and shelf life.  
 After a long storage period, all food products including fruit juices are subjected to 
spoilage, leading to quality degradation. The main target of scientists and manufacturers is to 
produce and deliver natural, safe, and healthy products with satisfactory shelf life. Physical, 
chemical, enzymatic, and microbial reactions can all cause spoilage (Could, 1996). However, all 
types of food spoilage can be prevented by preservative techniques, such as encapsulation, which 
can be applied to provide high quality food products. Various other preservative techniques that 
can be applied to food products to inhibit microbial growth are chilling, freezing, drying, curing, 
and vacuuming. Microbial growth can also be inactivated by irradiation and pasteurization and 
can be restricted by packaging and aseptic processes. Also, multiple techniques have been 
developed, such as ultrahigh pressure, bacteriolytic enzymes, electroporation, and nano-
thermosonication to prevent spoilage (Could, 1996).  
Fruits and vegetables products can undergo physical degradation during storage since 
they do not receive heat treatment. Physical damage can trigger chemical or microbiological 
spoilage, which can be enhanced in opened containers and dented cans. Various types of 
oxidation can result in chemical degradation. Chemical degradation can affect the color of 
products, such as forming yellow and brown pigments, haze, and sediments (Spanos et al., 
1990). Siebert et al (1996) conducted a study proposing that turbidmetric methods used to 
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 measure haze-active proteins and polyphenols in beverages also affect the stabilization 
procedures, so proteins that lack proline were found to have little or no haze when polyphenols 
were added. In fruit juices, polysaccharides increase haze. Beverages such as orange, grapefruit 
and apple juice have higher proline, which is an active polyphenol. an active polyphenol is 
highest in fruit juices, which may cause beverage destabilization. Proline is an important 
component of proteins that bind to polyphenols. Incidentally, free proline competes with haze-
active protein in binding to polyphenols. Free amino acid-polyphenol complexes are smaller and 
are capable of being more soluble than protein-polyphenol complexes (Siebert et al., 1996). 
Haze-forming polyphenols contain two binding groups. Each has two hydroxy groups on an 
aromatic ring. The ratio of protein and polyphenol strongly influences the amount of haze 
formed. When there is a large amount of proteins, the numbers of polyphenol binding ends and 
protein binding sites become almost equal; thus, it is important to stabilize beverages to delay 
haze formation (Siebert, 1999). Normally, these beverages are stabilized to delay the onset of 
protein-polyphenol haze formation. As a result, the shelf life of food products can be limited 
when certain compounds are formed or flavor and nutrients are lost. It is essential to use a 
pasteurization technique to prolong the shelf life of fruit beverages and prevent the formation of 
off-flavor, odor, and loss of nutritional value. 
Lactic acid bacterium and Lactobacillus spp. and Leuconostoc spp. causes spoilage and 
undesirable flavor and odor in some fruit juice. Lactobacillus spp and Leuconostoc spp cannot 
flourish in such high sugar concentrations or at low temperature (for example,45% sucrose and 
5◦C ), even though the pH range of apple juice is between 3.0 and 4.5 which is an ideal range for 
Lactobacillus spp. and Leuconostoc spp to survive. Additionally, apple juice can become spoiled 
by E. coli O157:H7 bacteria, mold, and yeast, if it is held at improper temperatures. Also, apple 
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 juice can become spoiled by yeast even if it is chilled. Therefore, pasteurization of apple juice is 
important to prevent microbiological degradation, although pasteurization processes may 
discolor apple juice (Evrendilek et al., 2000). Nano-encapsulation provides protection of proteins 
and peptide under extreme temperatures and pH (Yin et al., 2004). 
 Nano-encapsulation can prolong the shelf life of food products and significantly enhance 
proteins and peptide performance. Furthermore, the natural deterioration of products can be 
prevented since the encapsulated products can withstand harsh environmental conditions such as 
30 to 60ºC and pH 1 to 12 (Yin et al., 2004). Furthermore, Nano-encapsulated proteins and 
peptides display great shelf life stability and long blood stream’ circulation time in vivo, which 
provide a control manner release and site specific delivery of proteins and peptides (Yin et al., 
2004). Nano-encapsulation of bioactives such as proteins and peptides can enhance the delivery 
of bioactives, increase shelf life stability, and prevent deterioration of food products during 
storage or as a result of the effect of extreme temperatures and pH. 
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Table 1.  Average nutrient content in apple juice (per 100 g) 
 
 
 
 
 
 
 
 
 
 
(Source: Gerhauser, 2008). 
 
Table 2. Polyphenol content of apple juice 
Phenolics  Apple juice (concentrate) per100g 
Total polyphenols 110 – 173 
Hydroxycinnamic acids 69 – 122 
Dihydrochalcones 9 – 54 
Flavan-3-ols: Mono- and dimers 14 – 32 
Flavonols (quercetin-glycosides) 4 – 7 
(Source: Gerhauser, 2008). 
 
 
  
Composition Apple juice(g) 
Water (g)  88.1 
Energy (kcal/kg) 48/203 
Protein (g) 0.07 
Carbohydrates (g) 11.1 
Fiber (g) 0.77 
Pectin (g) 0.032 
Potassium (g) 116 
Calcium (g) 4.2 
Magnesium (g) 6.9 
Phosphorus (g) 7.0 
Organic fruit acids  0.74 
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 CHAPTER 3 
Preparation of nanoparticle, and investigation of the physical attributes and stability 
pentapeptide in apple juice. 
Fatima Alessa, Navam Hettiarachchy*, Srinivas J. Rayaprolu, Madhue Ravichandran , Mourad 
Benamara, Denise Greathouse, Surendra Singh 
INTRODUCTION 
Nanotechnology is a technique that provides potential benefits for both producers and 
consumers by the delivery of bioactive, antimicrobials, and improving flavor and color of food 
products (Onwulata, 2012; Zemit et al., 2011; Mukha et al., 2013). Nano-encapsulation is 
defined as “forming particles loaded with ingredients in diameters of 100 nm” (Reis et al., 2005). 
Nanoparticles are an ideal encapsulation approach for functional foods and recently has been 
used in several food applications including manufacturing and processing (Luykx, et al., 2008). 
Nanoparticles can increase the stability and controlled release of bioactives due to their small 
particle size in comparison to particles in micrometer sizes (Hans and Lowman, 2002). Food 
grade polymers (copolymers) are extensively used as controlled release carriers for protein 
preparation because of their biodegradability and compatibility; especially Poly lactic glycolic 
acid (PLGA), which is a copolymer of polylactic acid (PLA) and polyglycolic acid (PGA) (Hans 
and Lowman, 2002). Poly lactic glycolic acid (PLGA) is the most common food grade polymer 
used in the preparation of nanoparticles. It dissolves at low concentrations in organic solvents 
such as dimethyl sulfoxide (DMSO) and is insoluble in water.  
A nono-precipitation method used in this study can be defined as a simple method of 
preparation and fabrication of polymeric nanoparticles such as PLGA. The formation of 
nanoparticles by nono-precipitation does not require any sophisticated equipment. It is a 
sensitive procedure with low energy cost and modest equipment in comparison with other 
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 methods such as emulsion/solvent diffusion, and a variety of solvents can be used such as 
DMSO. Furthermore, this method aids in preparing nanodispersion in one step, decreasing 
energy input, and increasing encapsulation yield (Boon-Seang Chue et al., 2007). The 
nanoprecipitation technique is the simplest method used to prepare nanoparticles, which involves 
two phases: the aqueous and organic phase. Since the polymer (PLGA) is insoluble in water, 
nanoprecipitation occurs as soon as the PLGA solution comes in contact with the dispersing 
phase. The emulsifier in the aqueous phase can stabilize and prevent aggregation of 
nanoparticles.  
Particle size is the most important characteristic, which can determine the success of 
encapsulating, loading, and releasing the pentapeptide. Peptides’ loading and release, and 
nanoparticles’ stability can be affected by particle size. Singh et al., (2009) reported that “The 
small size of nanoparticles allows for efficient uptake by a variety of cells type and selective 
drug accumulation at target sites”. A laser particle size analyzer is an instrument that is widely 
used for particle size analysis. A laser particle size analyzer is a useful instrument to measure the 
particle size of nanoparticles since it includes a laser device. This instrument is sophisticated but 
used friendly and has the capability to analyze a broad range of particles in a variety of 
dispersion media. It requires only three minutes for the measurement and analysis of particle size 
(A guidebook to particle size analysis, 2012). The particles first will pass through a laser beam, 
and the light that scattered will be collected in the forward direction over a range of angle. To 
yield the distribution of particle size, the scattered intensity distribution is analyzed by computer. 
The particles size is important to be measured because it can potentially affect the stability of 
nanoparticles (A guidebook to particle size analysis, 2012). 
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  The HPLC reversed phase chromatography (RP) has been used to test the stability of 
bioactives, and it has been widely used in the area of biochemical separation and purification. 
For instance, proteins and peptides possess some degree of hydrophobic character; therefore, 
they can be separated by reversed phase column chromatography with excellent recovery and 
resolution properties. According to Amersham Biosciences (1999) the mechanism of reverse 
phase HPLC involves binding hydrophobic molecules in the solute during the mobile phase and 
the hydrophobic ligand in the stationary phase. 
Responding to the consumer demand for high quality attributes is a crucial step in 
maintaining the product’s success in the market. It was found in several studies that consumers 
are first attracted by the appearance of food products before the health benefits of products 
(Tuorila and Cardello, 2002; Urala and Lahteenmaki, 2007). Therefore, conducting an analysis 
of physical attributes is crucial to assess the quality of apple juice after the addition of 
pentapeptide and nanoparticles. PH and color, in apple juice are important parameters that should 
be monitored during storage with and without nanoparticles and could affect the physical 
attributes of apple juice.  
Experiments were conducted to investigate the stability of Nano-encapsulated 
pentapeptide incorporated apple juice for 6 month at 4° C.  
MATERIALS 
The following materials were used to prepare nanoparticles. Apple juice concentrate was 
purchased from a local grocery store. Poly-lactic-glycolic acid (PLGA) was purchased from 
Boehringer Ingelheim Chemicals, Inc. (Ingelheim, Germany). Dimethylsulfoxide (DMSO) was 
purchased from Fisher Scientific (Fair Lawn, NJ). Polyvinyl alcohol (PVA) was purchased from 
Kuraray (NewYork, NY).  
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 To investigate the shelf life stability of Nano-encapsulated pentapeptide incorporated in 
apple juice, the following instruments were used: particle size analyzer Model BI-9000ATDigital 
Correlator, Brookhaven Instruments Corporation (Holtsville, NY) was used at Dr. Surendra 
Singh’s laboratory Department of Physics University of Arkansas, Fayetteville, AR.  Scan 
electron microscopy FEI NOVA Nanolab Department of Nanotechnology University of 
Arkansas, Fayetteville, AR was used for scanning the nanoparticles. A biopore C-18 preparative 
high–performance liquid chromatography HPLC column (Biopore Prep ID 22 XL 250 nm part # 
34955) was used to analyze the nanoparticles and pentapeptide. The chemicals for HPLC were 
purchased from Sigma (St.Louis, MO). Ultra-centrifuge Model J2-21 from Beckman Inc.(Brea, 
CA) was used to separate the nanoparticles at Dr. Denise Greathouse’s laboratory Department of 
Chemistry University of Arkansas, Fayetteville, AR. The ultracentrifuge tubes to separate the 
nanoparticles were purchased from Beckman Coulter (Brea, CA).  
To evaluate the physiochemical properties of nanoparticles and Nano-encapsulated 
pentapeptide in apple juice, the following instruments were used: pH meter from Orion Research 
Inc. (Boston, USA), refractometer from Atago Inc. (Osaka, Japan), Chroma- meter from Minolta 
Inc. (Osaka, Japan), Tryptic Soy Agar for total plate count (TPC) and Potato Dextrose Agar 
(PDA) for mold and yeast were procured from Becton Dickinson and company (Spark, MD). 
METHODS 
Preparation of nanoparticle using PLGA polymer and incorporation in apple juice. 
The procedure developed in Dr. Hettiarachchy’s lab was followed to prepare the 
nanoparticles. Nano-precipitation method consisted of two phases: organic and aqueous phase. 
Initially, the organic phase of nanoparticle were prepared by slowly adding 0.75g PLGA 503 H 
monomer to 15.0 ml DMSO while stirring using magnetic stirrer until all the contents were 
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 dissolved. Then, the aqueous phase was prepared by adding 0.05g polyvinyl alcohol (PVA) to 10 
ml of de-ionized (DI) water pH (3.7) while stirring by magnetic stirrer until all contents were 
dissolved. While the organic phase was stirring, 3.0 ml were taken by syringe (3cc, 23GI syringe 
and precision glide needle) from the organic phase and slowly injected into the aqueous phase to 
form nanoparticles. The nanoparticles were formed in contact with aqueous phase due to the 
immiscibility of organic phase consisting of pentapeptide and PLGA in water. The particle size 
of nanoparticles was measured by a laser particle size analyzer.  
The nano-precipitation method was used as described above to encapsulate the 
pentapeptide. The organic phase of the nanoparticles was prepared by slowly adding 0.75g 
PLGA 503 H monomer to 15.0 ml DMSO while stirring until all the contents were dissolved. 
Pentapeptide at concentrations (200/400/ 600µg/ml) were added to the organic phase while 
stirring. These three concentrations were calculated based on an inhibitory concentration of 
cancer cell lines by 50% (IC 50) from a study conducted by Kannan et al (2009). The aqueous 
phase was prepared by adding 0.05g polyvinyl alcohol (PVA) to 10 ml of apple juice, which was 
prepared by mixing one part apple juice concentrate and three parts water to achieve the total 
soluble solids of 11 ºBrix (determines the consistency and solubility of the food product) and 
stirred until all contents were dissolved. Three milliliters of the organic phase were taken using a 
syringe and were slowly injected into the aqueous phase to form nanoparticles. Three controls of 
apple juice were also prepared: 1. 10.0 ml apple juice, 2. 10.0 ml of apple juice and 
nanoparticles, 3. 10.0 ml water with nanoparticles only. The samples were pasteurized at 71°C 
for 15 seconds as per FDA recommendation (Korhonen et al., 1998), and stored at 4 °C. The 
particle size and the stability of pentapeptide were tested before and after pasteurization using a 
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 particle size analyzer. The products were stored at 4 °C for the duration of the study and 
evaluated at periodic intervals from 0, 2, 7, 14, 30 days, and monthly up to 6 months. 
Preparation of a standard curve to determine pentapeptide concentrations. 
A series of dilution of pentapeptide from 200, 400, 600, 1000, 1200, and 1600 µg/ml was 
prepared. The pH was adjusted to 3.7 to mimic the pH of apple juice. High performance liquid 
chromatography with C18 column was used. The solvents used were 0.1 %TFA in and 
acetonitrile 50: 50 and 0.1 %TFA, at a flow rate 1ml/min with 10µl injection volume for 45min 
at 215 nm.  
Stability of Nano-encapsulated pentapeptide in pasteurized apple juice by HPLC. 
HPLC method (Kannan et al., 2009) was followed to investigate the stability of the 
pentapeptide. The samples of pentapeptide in water, pentapeptide in apple juice, Nano-
encapsulated pentapeptide in DI water at pH 3.7 and in apple juice with 200,400, and 600µg/ml 
and apple juice were analyzed by HPLC (RP) C18 column. The samples of Nano-encapsulated 
pentapeptide in water and apple juice with three different concentrations of pentapeptide 
(200/400/600µg/ml), the controls of nanoparticles in water were ultra-centrifuged at 60,000 rpm 
(120,000x g) for 30 min and 4 ºC to separate the nanoparticles from the solution. The 
supernatants were collected and filtered through 20µm filter before sequencing to the HPLC 
analysis. The solvents used were 0.1 %TFA in acetonitrile 50: 50 and 0.1 %TFA in water, flow 
rate 1.00 ml/min, wavelength 215nm. 
Statistical analysis.  
 The statistical analysis was conducted using the GLM procedure of SAS 9.3 (SAS 
Institute, Cary, NC) and the stability of the Nano-encapsulated pentapeptide was studied using 
the 3 factor factorial completely randomized design. 
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 Measurement of the particle size of Nano-encapsulated pentapeptide in pasteurized apple 
juice. 
The particle size was measured after pasteurization to determine the effect of 
pasteurization on the nanoparticles stability. The mean particle diameter of nanoparticles 
prepared for delivering bioactives was measured by a laser particle size analyzer. In a culture 
tube, 50.0 μl of the Nano-encapsulated pentapeptide incorporated into apple juice with three 
concentrations of pentapeptide (200/400/600µg/ml)) was added to 10.0 ml of DI water 
separately. The solution was taken from the culture tube and added to the sample holder that was 
housed in the instrument. The sample holder was placed in the chamber of the laser particle size 
analyzer and the lid was closed. While testing the samples, the first window of the detection kept 
at 400 µm. The second window adjusted to 633 nm, and the time of running the samples was 
adjusted to 2 minutes. The resulting measurements of particle size were recorded. 
Scan electron microscopy (SEM) in Nano-encapsulated pentapeptide in pasteurized apple 
juice. 
SEM was used to image nanoparticles because it provides morphological and chemical 
information which is important in determining the stability of nanoparticles (Utsunomiy and 
Ewing, 2003, Musumeci et al., 2006, and Hafner, 2007). Vacuum conditions and electrons are 
used in SEM to form a magnified image. The sample of Nano-encapsulated pentapeptide in 
apple juice with 400µg/ml was dried by placing a drop of the sample on a double-sided tape 
attached on a metallic sample stand for 48 h at room temperature before the analysis. The 
double-sided tape attached on a metallic sample stand coated under argon atmosphere with a thin 
layer of gold. The main components to form an image in SEM are shown in Figure 1; the 
microscope column, specimen camber, and the vacuum system. The black box of the SEM 
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 consists of an electron gun, which was the source of the electron beam, a series of lenses 
including condenser and objective, which was used to control the diameter of the beam and focus 
the beam on the specimen. Specimen position controllers were used to expose an area of 
beam/specimen interaction, which produced the image of nanoparticles by generating several 
detectable signals. 
Testing physical properties of pasteurized apple juice with nanoparticles (contain 
pentapeptide). 
The samples of pentapeptide in water, pentapeptide in apple juice, apple juice, Nano-
encapsulated pentapeptide in DI water (pH 3.7) and in apple juice at 200/400/ 600µg/ml, were 
tested for color and microbiological attributes. All the measurements were conducted for 
triplicate samples. The procedures of the physical properties are as follow.  
a. Color  
A Chroma-meter was used to measure the color using white tile to calibrate the 
instrument.  The apple juice samples were measured in triplicate. The color values L, a, and b 
were recorded. The L is a measure of brightness or whiteness, which ranges from 0 to 100 (If L 
=100, the sample will be white, and if L=0, the sample will be black). The parameter a is a 
measure of redness, which ranges from – a to + a (green= - a and red= + a). b is a parameter to 
measure the yellowness, which ranges from – b to + b (blue= - b and yellow= + b). The 
differences of color were calculated by following equations: 
∆ E* ab= √(∆ L*)2 + √(∆a*)2+ √(∆ b*)2  
Chroma= (a^2+b^2)1/2  
Hue= arc tan (a/b)  
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 b. Enumeration of microbial survivors  
The microbiology test was conducted to determine the effect of pasteurization 
(Evrendilek et al., 2000). Microbial inactivation and growth were determined during the storage 
period using the total plate count (TPC), and plate count for mold and yeast. Trypticase soy agar 
pour plate (TSA) to determine the total plate count (TPC). Sterile peptone water (0.1 % w/v) was 
used to dilute the samples, which were plated total plate count agar. Potato dextrose agar (PDA) 
was used for yeast and mold counts. The colonies were counted after incubating TSA plates at 30 
°C for 48 hours, and at 22 °C for 5 days for PDA plates (Evrendilek et al., 2000).  
c. (Brix) Total soluble solid 
 Total soluble solids (TSS) is an important parameter that defined the consistency and 
solubility of apple juice. A refractometer was used to measure total soluble solids of apple juice 
at ambient temperature. The recommended TSS for apple juice is 11.00 ºBrix.  
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Figure 1: The main elements of Scan Elements Microscopy. 
 (Source:  Hafner, 2007) 
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 RESULTS AND DISCUSSION 
Stability of pentapeptide incorporated nanoparticles in pasteurized apple juice by HPLC. 
The pH of DI water (pH 6.9) was adjusted to a 3.7 to match that of apple juice for 
comparison of the stability of Nano-encapsulated pentapeptide over the storage period. The 
percentage degradation of pentapeptide at three different concentrations (in water and apple 
juice) over the storage period was calculated using the equation derived from the standard curve 
plot (R2 = 0.99) (Figure 2). All the samples were conducted for duplicates. Figure 2 shows the 
standard curve with the following equation  
Concentration (µg/ml) = (area+ 47.421)/ 1.539  
Pure apple juice (reconstituted from concentrate) was spiked on the HPLC column to 
show the absence of any peptides that have the same retention time as the pentapeptide. The 
apple juice containing known concentrations of pentapeptide (200/400/600µg/ml) was spiked to 
confirm the retention time of the pentapeptide which was between 11 and 13 minutes from the 
start of the run.  Figures 3 to 5 (a - f) are the HPLC profiles of the non-encapsulated pentapeptide 
in water (pH of 3.7) showing degradation over time. The HPLC analysis showed significant 
degradation (P value <0.001) of non-encapsulated pentapeptide (at three different 
concentrations) in water from the 0 day: (200ug/mL – 87.8%, 400ug/mL – 97.4%, 600ug/mL – 
91.9%) to the 60th day: (200ug/mL – 41.8%, 400ug/mL – 60.8%, 600ug/mL – 55.8%) of storage. 
This could be due to the low pH (3.7) of the solution and possible interactions between the 
pentapeptide and water molecules which are confirmed by similar previous studies (Toll e t al., 
2005).  
Figure 6 (a-f) shows the HPLC profile of apple juice alone, which is composed of organic 
acids including quinic acid, citric acid, galacturonic acid, and malic acid, and amino acids 
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 including aspartic, asparagine and glutamic acids (Timberlake, 1957). Previous studies have 
shown similar retention times for organic / amino acids as in Figure 6 (Nour et al., 2010). The 
HPLC profiles Figures 7 to 9 (a - f) show the non-encapsulated pentapeptide at three different 
concentrations in apple juice with significant degradation over storage period 0 day: (200ug/mL 
– 96.6%, 400ug/mL – 98.1%, 600ug/mL – 94.5%) to the 60th day: (200ug/mL – 60.6%, 
400ug/mL – 67.5%, 600ug/mL – 59.1%). The effect of pH and the possible interactions with the 
components of apple juice (organic and amino acids) are the possible reasons for the degradation 
of the pentapeptide which is shown in Figures 10 and 11.  It was observed that the pentapeptide 
degraded over the storage period of 60 days in both water and apple juice at pH of 3.7 and 
temperature 4ºC. The results imply that the degradation of pentapeptide in apple juice over the 
storage period decreased in a way similar to the degradation of pentapeptide in water. However, 
the IC50 concentration (400µg/ml) shows better stability in apple juice than the lowest and 
highest concentrations of pentapeptide (200/600µg/ml) respectively. This might be due to the 
acidic environment of apple juice, concentration of pentapeptide, and interactions between 
bioactive pentapeptide and apple juice matrix.  
In present study the nanoparticles was used to encapsulate the bioactive pentapeptide in 
apple juice. This study also aimed to evaluate the enhancement of shelf life and delivery of 
pentapeptide in apple juice over a period of 60 days.  Figures 12-19 (a-f) show the HPLC profiles 
of Nano-encapsulated pentapeptide incorporated in water at pH of 3.7 and apple juice are stable 
over the storage period of 60 days. The absence of pentapeptide peak implies that the 
pentapeptide remained encapsulated within the PLGA nanoparticles during the storage period. In 
this case, Figure 20 shows an illustration of nanoparticles and pentapeptide attached through 
electrostatic interaction. The electrostatic interactions occur when the nanoparticles that have the 
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 negatively/positively charged surface attach to the peptide which has the opposite charge. In a 
study conducted by Khairallah (2011), peptide fractions derived from rice bran were 
incorporated in orange juice to test the storage stability. The peptide fractions’ were found to 
degrade significantly during the 0 to 42 day storage period. The researcher indicated that the 
degradation might have occurred due to interactions between peptide fractions and the orange 
juice components. Therefore, encapsulating the pentapeptide can considerably reduce the 
interactions and potentially lead to prolonged stability.  
Particle size of Nano-encapsulated pentapeptide in pasteurized apple juice. 
Particle size is the most important characteristic that should be monitored for successful 
encapsulation, loading, and release of pentapeptide. This can also affect nanoparticle stability 
and the delivery of bioactives. Particle size of pasteurized Nano-encapsulated pentapeptide in 
water (pH of 3.7) at varying concentrations of pentapeptide (200/400/600µg/ml) was measured 
from day 0 to day 60 using particle size analyzer. Figure 21 shows the particle size of the 
nanoparticles which ranged from 82 to 83nm and remained stable during the storage period with 
(P value <0.05%). The uniformity of the particle diameter indicated that the prepared 
nanoparticles were of even size and the pasteurization had no deleterious effect. Particle size for 
Nano-encapsulated pentapeptide in apple juice with varying concentrations of pentapeptide 
(200/400/600µg/ml) was measured from 0 to 60 days, and the diameter of particle size ranged 
from 82 to 83nm. The results from the particle size analysis showed successful stability of 
pentapeptide since they had large surface area to the volume ratio. Similar observations were 
recorded on Ravichandran et al (2011) and Ganea et al., (2010) studies.  
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 Scan electron microscopy (SEM) of Nano-encapsulated pentapeptide in pasteurized apple 
juice 
SEM was used to determine the form and stability of nanoparticles during the storage 
period. Images of the Nano-encapsulated pentapeptide (400µg/ml) in apple juice were taken at 0, 
2, 7, 14, 30, and 60 days of storage period using the SEM.  Figure 22 shows the SEM images of 
the Nano-encapsulated pentapeptide in apple juice at IC50 (400µg/ml) from 0 day to 60 day 
storage. The nanoparticles showed spheroidal shape, which was stable over the storage period. 
Thus, it can be concluded that the Nano-encapsulation provided protection from degradation to 
the pentapeptide in the apple juice environment. Similar images were observed on Bilati et al 
(2005).and Ganea et al., (2010) studies.  
Physical properties of Nano-encapsulated pentapeptide in pasteurized apple juice 
a. Color  
Color is an important parameter which can provide an image for the consumer about the 
quality and acceptance of a food product. The analysis of the apple juice color was based on the 
lightness (L), redness (a*), and yellowness (b*). Chroma (Cr) is a significant parameter of color 
which indicates the intensity and relates to consumer appeal. Hue of a food product indicates the 
actual color of the material and contributes to the overall color expectation from the product. 
Total color difference, ΔE, is the magnitude of overall color difference compared between the 
apple juice alone (control) and the Nano-encapsulated pentapeptide in apple juice (Lee and 
Coates, 1999). Figures 23, 24 and 25 show Chroma, Hue, and ΔE respectively for the two 
beverage samples over the storage period of 0 to 60 days. 
 Chroma of apple juice alone did not show any significant changes during the storage 
period. For the apple juice incorporated with varying concentrations of pentapeptide 
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 (200/400/600µg/ml) Cr measurements over the storage period (0-60 days) ranged from 0.5 to 
0.3. The results indicated that there was no significant change in the Cr values among the three 
concentrations of pentapeptide in apple juice (controls). The Cr of Nano-encapsulated 
pentapeptide in apple juice during the storage period ranged from 3.2 to 2.8, which indicated no 
significant change of the Cr value during storage period of 60 days. The pasteurization of the 
nanoparticles did not affect the Cr during storage. However, there was significant difference 
between the Chroma of non-encapsulated pentapeptide in apple juice and the Nano-encapsulated 
pentapeptide and confirmed with (p- value 0.001).    
The Hue angle of the apple juice alone was stable over the storage period of 60 days, and 
it was intensely colored (Yellow). The Hue angle of apple juice containing varying 
concentrations of pentapeptide (200/400/600µg/ml) ranged from -0.1 to 0.1. There is no 
difference in the Hue among the three concentrations of pentapeptide incorporated apple juice. In 
a previous study investigating the stability of peptide fractions in orange juice, the changes in the 
color of orange juice control samples and the orange juice with rice bran peptide fractions was 
similar over the storage time of the study (Khairallah, 2011). These results are consistent with 
our findings. The results indicated that the Hue of the Nano-encapsulated pentapeptide in apple 
juice was stable over the storage period which showed Light yellow color. The negative values 
for Hue angles might be due to the negative values of a* since the Hue angle is a function of a* 
and b* values.  
Total color difference, ΔE, during the storage period of 60 days between the apple juice 
and the Nano-encapsulated pentapeptide in apple juice ranged from 15.2 to 14.2. The results 
from the color studies indicated significant differences between the apple juice alone (control) 
and apple juice with the Nano-encapsulated pentapeptide. The difference in color remained 
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 consistent during the storage period, days 0 to 60 which is attributed to the addition of 
nanoparticles which were white in colors. These changes in color are significant between the 
treatments (apple juice and Nano-encapsulated pentapeptide); while there was no significant 
changes over the storage time. The pasteurization temperature of 71ºC for 30 seconds did not 
affect the color during the storage period. Pasteurization and low storage temperature of 4ºC 
were effective in preventing significant changes or deterioration of color during storage which is 
consistent with published research (Burdurlu et al., 2003). 
b. Enumeration of microbial survivors  
The microbial growth was determined during the storage period using Tryptic Soy Agar 
(TSA) pour plates used for the total plate count (TPC). The Potato Dextrose Agar (PDA) was 
used to count the yeast and mold colonies. The TPC and PDA agar plates were prepared to 
enumerate the microbial colonies during the entire shelf life of the control samples, pentapeptide 
incorporated in water and apple juice, and Nano-encapsulated pentapeptide in apple juice. No 
microbial growth was observed on both TSA and PDA plates during the storage period of 60 
days, which indicated that the pasteurization of apple juice at 71ºC was effective in inhibiting 
microbial growth. Furthermore, apple juice is rich in phytochemicals, which can be defined as 
non-nutrient plant components including polyphenols, flavonoids, hydroxycinnamic acids, 
dihydrochalcones, flavonols (quercetin glycosides), catechins and oligomeric procyanidins which 
are known for antioxidant activities (Gerhauser, 2008). These phytochemicals have also shown 
significant antimicrobial activity against pathogenic microorganisms including E.coli, 
L.monocytogenes, and S. aureus that cause diseases in human (Alberto et al., 2008).  
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 c. Acidity (pH) 
The pH of apple juice is an important factor that can determine the stability of 
pentapeptide. The pH of the Nano-encapsulated pentapeptide in apple juice samples and the 
controls from zero to 30 days did not show any significant change. The results indicated that the 
pH remained stable for the samples at 3.7, which is within the range of apple juice pH (3.00 to 
4.00) that prevented any degradation of the nutritional components. After 60 days the pH of the 
(controls) pentapeptide in apple juice with varying concentrations (200/400/600µg/ml) dropped 
to 3.3, which was not significant, since it is still in acceptable range pH 3.0- 4.0. This change in 
pH might be due to the glutamic acid in the pentapeptide, which is negatively charged that 
maintained the pH in the acidic range (Khairallah, 2011). In the previous study on the stability of 
peptide fractions in orange juice at pH 3.5 the peptide fractions showed stability throughout the 
study in comparison to peptide fractions in orange juice stored at pH 7.2 (Khairallah, 2011). The 
addition of pentapeptide did not affect the pH of apple juice since there was no significant 
difference between apple juice and pentapeptide incorporated apple juice. Similar observations 
were recorded by previous researchers on the stability of proteins and protein hydrolysates in 
acidic beverages (Khairallah 2011 and Kazmerski et al., 2003). 
d. Total soluble solid (Brix) 
Total soluble solid (TSS) is a significant factor to determine the consistency of color, 
clarity and solubility of apple juice. The TSS of apple juice was adjusted to 11 ºBrix which is 
consistent with that of commercially available apple juice. The total soluble solids of the control 
samples, apple juice alone and pentapeptide incorporated apple juice, at 0, 2, 7, 14, 30, and 60 
days were 11 and 11.3 ºbrix respectively. This implies that the incorporation of pentapeptide in 
the apple juice did not significantly affect the TSS over time.  The consistency of apple juice 
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 (control) was not visibly different from the pentapeptide incorporated apple juice with three 
various concentrations. The TSS of Nano-encapsulated pentapeptide in apple juice at 0, 2,7,14, 
30 and 60 days was 31 ºBrix. Hence, there was a significant difference in TSS between the 
control samples and the Nano- encapsulated pentapeptide in apple juice which was due to the 
addition of PLGA nanoparticles, which requires addition of PLGA (0.75g) to (10 ml) of apple 
juice. However, the consistency of Nano-encapsulated apple juice is not visibly different from 
some of the commercially apple juice (manufacture name: nudie and Pip organic).   
Conclusion 
Encapsulation technique used in the food industry has increased because it provides 
protection for the encapsulated materials from moisture, heat, and other extreme conditions in 
food environment. Hence, the encapsulation can potentially enhance the stability and maintain 
viability of bioactive compounds (Gibbs, et al., 1999). Encapsulation is defined as an 
incorporation of bioactive compounds in a small capsule.  In general, encapsulation technique 
involved three steps: (1) forming the wall around the bioactive compounds (2) preventing the 
leakage of the bioactive (3) removing undesirable materials out of the capsule (Gibbs, et al., 
1999). The most common copolymer are used in the food industry is PLGA due to its 
biodegradability and compatibility. PLGA has been extensively used to deliver proteins and 
peptide and it is approved by FDA (Makadia et al, 2011). PLGA can be degraded in vivo 
enzymatically or non-enzymatically producing tow toxicologically safe monomers (Makadia et 
al, 2011).  
Nano-precipitation method was used to prepare Nano-encapsulated pentapeptide since it 
is a simple method of preparation and fabrication of polymeric nanoparticles such as PLGA 
(Schubert et al., 2011). The formation of nanoparticles by nano-precipitation does not require 
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 any external input such as high shearing, sonication, or homogenization (Schubert et al., 2011). 
It is a sensitive procedure with low energy cost and modest equipment, and a variety of solvents 
can be used such as DMSO or acetone. Furthermore, this method aids in preparing 
nanodispersion in one step, decreasing energy input, and increasing encapsulation yield 
(Schubert et al., 2011).  
Recently, role of proteins in a diet as physiologically active compounds have arisen 
(Korhonen and Pihlanto, 2003)). Proteins are the main source of bioactive compounds such as 
active peptides. Peptides provide several unique features in comparison to proteins and lipids; 
thus, they are more efficient for therapeutic delivery applications. They exhibit various activities 
such as anti-cancer, anti-hypertension, and antioxidant (Korhonen and Pihlanto, 2003). Peptides 
can be easily sequenced and synthesized in the laboratory; therefore, they are economical. 
Peptides can be very specific and bind with high affinity to their cognate receptors, since they are 
naturally occurring from protein precursors (Delehanty et al., 2010). Active peptides derived 
from cereal grains have potentially impacted on cancer prevention and treatment. For example, 
bioactive pentapeptide derived from rice bran has shown to inhibit colon cell proliferation 
(Kannan et al., 2008).  Multifunctional groups of peptides can be incorporated into the 
nanoparticles (NPS) to produce a ‘value-added’ material that serves multiple purposes in one NP 
(Delehanty et al., 2010). Peptides are very attractive and useful molecules for the evolution of 
NPs. however, maintaining biactivity and stability of peptides are two main challenges facing the 
food industry. Nano-encapsulation of these bioactives can potentially maintain the stability and 
prevent degration of bioactive peptides during storage period (Allémann et al., 1998). The 
demand on nanocomposution has increased based on global market report. In 2010, the 
consumption of nanocompsution was over $ 800 milion, increased to $ 920 milion in 2011, and it 
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 is expected to reach $ 2.4 milion by 2016 (BCC research). Nano-encapsulation of anticancer 
pentapeptide will have a great impact on improving public health and wellness since cancer one 
of the most leading causes of death in the U.S. 
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Figure 2: Standard curve of pentapeptide at increasing concentrations based on peak areas 
from retention times on an affinity HPLC column. 
 
 
 
 
 
 
 
 
 
 
 
 
y = 1.4539x - 47.421
R² = 0.9993
0
500
1000
1500
2000
2500
0 500 1000 1500 2000
pe
ak
 a
re
a 
peptides concentrations µg/ml 
48 
 
  
Figure 3-a day 0 
 
. 
Figure 3-b day 2 
 
Figure 3-c day 7 
 
Figure 3-d day 14 
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Figure 3-e day 30 
 
Figure 3-f day 60 
 
Figure 3(a-f): HPLC profiles of the pentapeptide (200µg/ml) incorporated in water at pH of 
3.7 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
retention time; 12.3, 12.3, 12.3, 11.9, 12.3, and 12.2 respectively.  Arrow a head shows the peak 
of the pentapeptide. Y-axis represents the absorbance units and the X-axis represents retention 
times 
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Figure 4-a day 0 
 
Figure4- b day 2 
 
Figure 4-c day 7 
 
Figure4-d day 14 
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Figure4-e day 30 
 
Figure 4-f day 60 
 
 
Figure 4(a-f): HPLC profiles of the pentapeptide (400µg/ml) incorporated in water at pH of 
3.7 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm 
.retention time; 12.1, 12.1, 12.1, 12.0, 12.0, and 11.7 respectively   Arrow a head shows the peak 
of the  pentapeptide. Y-axis represents the absorbance units and the X-axis represents retention 
times 
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Figure 5-a day0 
 
Figure5-b day2 
 
Figure5-c day 7 
 
 Figure 5-d day 14s 
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Figure5-e day 30 
 
Figure 5-f day 60 
 
 
Figure 5(a-f): HPLC profiles of the pentapeptide (600µg/ml) incorporated in water 
at pH of 3.7. 
 
 Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
Retention time of pentapeptide: 12.0, 12.0, 12.0, 11.7 , 11.9, and 12.4 respectively ; Arrow a 
head shows the peak of the  pentapeptide.  Y-axis represents the absorbance units and the X-axis 
represents retention times 
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Figure 6- a day 0 
 
Figure 6-b day 2 
 
Figure 6-c day 7 
 
Figure 6-d day 14 
 
Figure 6-e day 30 
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Figure 6-f day 60 
 
Figure 6(a-F): HPLC profiles of apple juice alone.  
 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. Y-
axis represents the absorbance units and the X-axis represents retention times 
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 Figure 7-d day 14 
 
Figure 7-e day 30 
 
 
Figure 7-f day 60 
 
Figure 7(a-f): HPLC profiles of the pentapeptide (200µg/ml) incorporated in apple juice. 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm; 
Retention time of pentapeptide: 12.2, 12.2, 12.2,12.3 ,12.2, and 11.7 respectively ; Arrow 
a head shows the peak of the  pentapeptide. Y-axis represents the absorbance units and the X-
axis represents retention times 
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Figure 8-a day 0 
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Figure 8-c day 7 
 
Figure 8-d day 14 
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Figure 8-f day 60 
 
Figure 8(a-f): HPLC profiles of the pentapeptide (400µg/ml) incorporated in apple 
juice.  
 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm; 
Retention time of pentapeptide: 12.1, 12.1, 12.1, 12.0, 12.2, and 12.0 respectively; Arrow 
a head shows the peak of the  pentapeptide. Y-axis represents the absorbance units and the X-
axis represents retention times 
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Figure 9-a day 0 
 
Figure 9-b day 2 
 
Figure 9-c day 7 
 
Figure 9-d day 14 
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Figure 9-e day 30 
 
Figure 9-f day 60 
 
 
Figure 9(a-f): HPLC profiles of the pentapeptide (600µg/ml) incorporated in apple juice. 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm; 
Retention time of pentapeptide: 12.0, 12.0, 12.0,12.3,12.0 , and 11.9 respectively ; Arrow a head 
shows the peak of the  pentapeptide. Y-axis represents the absorbance units and the X-axis 
represents retention times 
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Figure 10: The stability of varying concentrations of pentapeptide in water at a pH of 3.7 
based on the percentage of pentapeptide degraded over the storage period. 
The values are represented as means of replicate analysis ± standard deviation with 
 (P value <0.00). 
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Figure 11:  The stability of varying concentrations of pentapeptide in apple juice based on 
the percentage of pentapeptide degraded over the storage period.  
The values are represented as means of replicate analysis ± standard deviation (P value <0.0001). 
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 Obs Treatment Days Concentration Peakarea Peptide Percentage 
1 AJ 0 200 230.10 190.880 95.4400 
2 W 0 200 207.10 175.060 87.3000 
3 AJ 0 200 237.30 195.830 97.9150 
4 W 0 200 209.00 176.360 88.1800 
5 AJ 0 400 522.80 392.200 98.0500 
6 W 0 400 523.00 392.330 98.0825 
7 AJ 0 400 524.20 393.160 98.2900 
8 W 0 400 515.50 387.180 96.7950 
9 AJ 0 600 777.70 567.500 94.5833 
10 W 0 600 705.30 517.700 86.2833 
11 W 0 600 805.00 586.290 97.7150 
12 AJ 2 200 230.10 190.880 95.4400 
13 AJ 2 200 230.10 190.880 95.4400 
14 W 2 200 207.10 175.060 87.5300 
15 AJ 2 400 521.90 391.580 97.8950 
16 W 2 200 209.00 176.360 88.1800 
17 AJ 2 400 518.70 389.380 97.3450 
18 W 2 400 501.20 377.340 94.3350 
19 AJ 2 600 739.35 541.100 90.1833 
20 W 2 400 515.50 387.180 96.7950 
21 W 2 600 633.80 460.840 76.8067 
22 W 2 600 625.40 460.294 76.7156 
23 AJ 7 200 225.90 187.990 93.9950 
24 AJ 7 200 230.10 190.880 95.4400 
25 W 7 200 172.20 151.050 75.5250 
26 AJ 7 400 446.80 339.920 84.9800 
27 W 7 200 178.80 155.590 77.7950 
28 AJ 7 400 474.60 359.040 89.7600 
29 W 7 400 495.10 373.140 93.2850 
30 AJ 7 600 702.00 515.450 85.9083 
31 W 7 400 488.40 368.540 92.1350 
32 AJ 7 600 702.00 515.450 85.9083 
33 W 7 600 622.60 468.540 78.0900 
34 W 7 600 621.80 462.760 77.1267 
35 AJ 14 200 220.90 184.550 92.2750 
36 AJ 14 200 219.90 183.860 91.9300 
37 W 14 200 132.70 123.880 61.9400 
38 AJ 14 400 446.80 335.730 83.9325 
39 W 14 200 130.20 122.160 61.0800 
40 AJ 14 400 440.70 331.600 82.9000 
41 W 14 400 468.60 342.810 85.7025 
42 AJ 14 600 685.60 504.170 84.0283 
43 W 14 400 450.00 354.920 88.7300 
44 AJ 14 600 702.00 515.450 85.9083 
64 
 
 45 W 14 600 583.50 433.900 72.3167 
46 W 14 600 627.55 438.500 73.0833 
47 AJ 30 200 187.30 161.440 80.7200 
48 AJ 30 200 192.50 165.010 82.5050 
49 W 30 200 130.20 122.160 61.0800 
50 AJ 30 400 440.70 339.920 84.9800 
51 W 30 200 122.60 116.940 58.4700 
52 AJ 30 400 434.70 335.730 83.9325 
53 W 30 400 451.00 354.920 88.7300 
54 AJ 30 600 426.90 326.240 54.3733 
55 W 30 400 468.60 342.120 85.5300 
56 AJ 30 600 652.80 481.610 80.2683 
57 W 30 600 531.80 398.390 66.3983 
58 W 30 600 540.80 404.580 67.4300 
59 AJ 60 200 . 95.700 47.8500 
60 W 60 200 64.00 76.600 38.3000 
61 AJ 60 200 166.30 147.021 73.5107 
62 W 60 200 84.60 90.851 45.4253 
63 AJ 60 400 346.00 270.597 67.6493 
64 W 60 400 269.30 217.865 54.4663 
65 AJ 60 400 345.00 269.909 67.4773 
66 W 60 400 343.30 268.763 67.1907 
67 AJ 60 600 513.60 385.919 64.3198 
68 W 60 600 417.60 319.890 53.3150 
69 AJ 60 600 423.60 324.017 54.0028 
70 W 60 600 462.30 350.612 58.4353 
 
Table 3: statistical analysis of pentapeptide in water at Ph of 3.7 and apple juice during 
storage period of 60 days. 
Source DF Sum of Squares Mean Square F Value Pr > F 
Model 35 14861.88322 424.62523 15.27 <.0001 
Error 34 945.21308 27.80038   Corrected Total 69 15807.09630     
Table 4: ANOVA table of pentapeptide in water at pH of 3.7 and apple juice. 
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Figure12 -e day 30 
 
Figure 12-f day 60 
 
Figure 12(a-f): HPLC profiles of Nano-encapsulated pentapeptide (200µg/ml) incorporated 
water at pH of 3.7. 
 Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
Arrow a head shows the peak of the solvent DMSO. Y-axis represents the absorbance units and 
the X-axis represents retention times 
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Figure 13-a day 0 
 
Figure 13-b day 2 
 
Figure 13-c day 7 
 
 
Figure13-d day 14 
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Figure 13-e day 30 
 
Figure 13-f day 60 
 
Figure 13(a-f): HPLC profiles of Nano-encapsulated pentapeptide (400µg/ml) incorporated 
water at pH of 3.7. 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
Arrow a head shows the peak of the solvent DMSO. Y-axis represents the absorbance units and 
the X-axis represents retention times 
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Figure 14-a day 0 
 
Figure 14-b day2 
 
Figure 14-c day 7 
 
Figure 14-d day 14 
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Figure 14-e day 30 
 
Figure-f day 60 
 
Figure 14: HPLC profiles of Nano-encapsulated pentapeptide (600µg/ml) incorporated 
water at pH of 3.7. 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
Arrow a head shows the peak of the solvent DMSO. Y-axis represents the absorbance units and 
the X-axis represents retention times 
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Figure 15-a day 0 
 
Figure 15-b day 2 
 
Figure 15-c day 7 
 
Figure 15-d day 14 
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Figure 15-e day 30 
 
Figure 15-f day 60 
 
Figure 15(a-f): HPLC profiles of Nanoparticles in water at pH of 3.7. 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
Arrow a head shows the peak of the solvent DMSO. Y-axis represents the absorbance units and 
the X-axis represents retention times 
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Figure 16-a day 0 
 
Figure 16-b day 2 
 
Figure 16-c day 7 
 
Figure 16-d day 14 
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Figure 16-e day 30 
 
 
Figure 16-f day 60 
 
 
 
Figure 16(a-f): HPLC profiles of Nano-encapsulated pentapeptide (200µg/ml) incorporated 
apple juice. 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
Arrow a head shows the peak of the solvent DMSO. Y-axis represents the absorbance units and 
the X-axis represents retention times 
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Figure 17-a 0 day 
 
 
Figure 17-b day 2 
 
 
Figure 17-c day 7 
 
Figure 17-d day 14 
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 Figure 17-e day 30 
 
Figure 17-f day 60 
 
Figure 17: HPLC profiles of Nano-encapsulated pentapeptide (400µg/ml) incorporated 
apple juice. 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
Arrow a head shows the peak of the solvent DMSO. Y-axis represents the absorbance units and 
the X-axis represents retention times 
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Figure 18-a day 0 
 
Figure 18-b day 2 
 
Figure 18-c day 7 
 
Figure 18-d day 14 
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Figure 18-e day 30 
 
Figure 18-f day 60 
 
Figure 18(a-f): HPLC profiles of Nano-encapsulated pentapeptide (600µg/ml) incorporated            
apple juice. 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
Arrow a head shows the peak of the  solvent DMSO. Y-axis represents the absorbance units and 
the X-axis represents retention times 
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Figure 19-a day 0 
 
Figure 19-b day 2 
 
Figure 19-c day 7 
 
Figure 19-d day 14 
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Figure 19-e day 30 
 
Figure 19-f day 60 
 
Figure 19(a-f): HPLC profiles of Nanoparticles in apple juice. 
Solvent system: 0.1 % TFA in water and 0.1 %TFA in acetonitrile in water (50%); Flow 
rate: 1ml/min; Injection volume: 10µl; Elution time: 45min; Absorbance measured: 215 nm. 
Arrow a head shows the peak of the  solvent DMSO. Y-axis represents the absorbance units and 
the X-axis represents retention times 
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 Figure 20: Illustration of electrostatic interactions between nanoparticles and peptide  
(Source: Delehanty et al., 2010). 
 
Figure 21: The particle size stability of Nano-encapsulated pentapeptide in apple juice 
(200/400/600µg/ml) over the storage period (0 to 60 days).  
The values are represented as means of replicate analysis ± standard deviation. (P value <0.05). 
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Figure 22: SEM image of Nano-encapsulated pentapeptide in apple juice. 
Images labeled a, b, c, d, e, f were taken at 0, 2, 7, 14, 30, and 60 days of storage respectively. 
Magnification: image a - 65.000x, image b - 65,000x, image c 50,000 x, image d 65,000x, image 
e 50,000x, and image f 65.000x respectively. The nanoparticles are indicated by arrows in all the 
images. 
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Figure 23: The Chroma changes of the Nano-encapsulated and non-encapsulated 
pentapeptide incorporated apple juice in storage.  
The values are represented as means of replicate analysis ± standard deviation with 
 (P value <0.0001). 
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Figure 24: The Hue Change of Nano-encapsulated and non-encapsulated pentapeptide 
incorporated apple juice in storage.  
The values are represented as means of replicate analysis ± standard deviation with 
 (P value< 0.001). 
 
 
Figure 25: The color change of Nano-encapsulated pentapeptide incorporated apple juice 
and control (apple juice) in storage. 
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